510(k) Process Issues Surface At FDA Appropriations Hearings
This article was originally published in The Gray Sheet
Executive Summary
Deputy FDA Commissioner Joshua Sharfstein told Congress he and incoming Commissioner Margaret Hamburg will be taking a look at the 510(k) clearance process to determine whether it is truly flawed, or just misunderstood